Want to see ADAPY full AI Analyst Report?

Adaptimmune Therapeutics (ADAPY) Technical Analysis

1,253 Followers

Technical Sentiment

Overall Consensus

Neutral

9Bullish

3Neutral

8Bearish

Technical Analysis Consensus

Sell

1Bullish

3Neutral

4Bearish

Moving Average Consensus

Buy

8Bullish

0Neutral

4Bearish

Try our new Technical Analysis Screener >

Adaptimmune Therapeutics’s (ADAPY) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Adaptimmune Therapeutics is a Sell.

Adaptimmune Therapeutics’s (ADAPY) 20-Day exponential moving average is 0.03, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.

Adaptimmune Therapeutics’s (ADAPY) 50-Day exponential moving average is 0.03, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.

Advanced Chart >

Adaptimmune Therapeutics (ADAPY) Pivot Points

Sep 07, 2026, 02:11 AM

Classic

>-0.01

0.01

0.02

0.04

0.06

Fibonacci

>-0.01

<0.01

0.01

0.02

0.03

0.04

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Adaptimmune Therapeutics (ADAPY) Moving Averages

Sep 07, 2026, 02:11 AM

MA5

0.03Buy

MA10

0.03Buy

MA20

0.03Buy

MA50

0.03Sell

0.03Buy

MA100

0.03Buy

0.03Sell

MA200

0.03Sell

0.04Sell

Adaptimmune Therapeutics’s (ADAPY) 10-Day exponential moving average is 0.03, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.

Adaptimmune Therapeutics’s (ADAPY) 100-Day exponential moving average is 0.03, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Sell.

Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 50-day simple moving average is 0.03, creating a Sell signal.

Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 100-day simple moving average is 0.03, creating a Buy signal.

Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 200-day simple moving average is 0.03, creating a Sell signal.

Adaptimmune Therapeutics (ADAPY) Technical Indicators

Sep 07, 2026, 02:11 AM

RSI (14)

51.78

Neutral

STOCH (9,6)

80.56

Sell

STOCHRSI (14)

79.17

Neutral

MACD (12,26)

>-0.01

Sell

ADX (14)

57.90

Sell

CCI (14)

2.44

Neutral

ATR (14)

<0.01

Ultimate Oscillator

76.03

Buy

Bull/Bear Power (13)

>-0.01

Sell

Adaptimmune Therapeutics’s (ADAPY) Relative Strength Index (RSI) is 51.78, creating a Neutral signal.

Adaptimmune Therapeutics’s (ADAPY) Trend Strength Indicator (ADX) is 57.90, creating a Sell signal.

Adaptimmune Therapeutics’s (ADAPY) Commodity Channel Index (CCI) is 2.44, creating a Neutral signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is ADAPY a Buy, Hold, or Sell?

Based on ADAPY’s technical indicators, ADAPY is a Hold.

What is ADAPY’s RSI (14)?

ADAPY’s RSI (14) is 51.78, which suggests ADAPY is a Neutral.

What is ADAPY’s MACD?

ADAPY’s MACD is >-0.01, which suggests ADAPY is a Sell.

What is ADAPY’s 5-day moving average?

ADAPY’s 5-day moving average is 0.03, which suggests ADAPY is a Buy.

What is ADAPY’s 20-day moving average?

ADAPY 20-day moving average is 0.03, which suggests ADAPY is a Buy.

What is ADAPY’s 50-day moving average?

ADAPY’s 50-day moving average is 0.03, which suggests ADAPY is a Sell.

What is ADAPY’s 200-day moving average?

ADAPY’s 200-day moving average is 0.03, which suggests ADAPY is a Sell.

What is ADAPY’s Williams % R (14)?

ADAPY’s Williams % R (14) is 0.00, which suggests ADAPY is a Buy.

What is ADAPY’s CCI (14)?

ADAPY’s CCI (14) is 2.44, which suggests ADAPY is a Neutral.